Alert: Major Price Decline (1/12/24)-Catalyst Biosciences Inc (NASDAQ: CBIO).

out_logo_500#72885.jpg

Catalyst Biosciences Inc (NASDAQ: CBIO) stock closed at $22.51 on 1/12/24 after a major decline of -14.6%. However, this decline was accompanied by unusually low trading volume at 58% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -6.8% during the last week.

out_mm#72885.jpg

Current PriceTarget Research Rating

With future capital returns forecasted to be below the cost of capital, CBIO is expected to be a major Value Eraser.

Catalyst Biosciences is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*